Protagen, MicroDiscovery Collaborate on Biomarkers | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German protein research firm Protagen this week said it and MicroDiscovery are collaborating to identify and validate biomarkers.

Protagen will use its UNIArray technology platform while MicroDiscovery will incorporate its software for the analysis of complex biomarker panels as part of the collaboration.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.